tiprankstipranks
Trending News
More News >
Replimune Group Inc (REPL)
NASDAQ:REPL

Compare Replimune Group (REPL) vs. Competitors

Compare
476 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Replimune Group
$8.23
$679.57M
-3.16
-26.12%
1 Buy
2 Hold
0 Sell
Moderate Buy
Anavex Life Sciences
$4.64
$430.00M
-13.95
-48.39%
1 Buy
0 Hold
0 Sell
Moderate Buy
Arcus Biosciences
$24.56
$3.08B
-7.25
161.00%
7 Buy
3 Hold
0 Sell
Moderate Buy
Oric Pharmaceuticals
$12.59
$1.26B
-5.55
65.01%
10 Buy
0 Hold
0 Sell
Strong Buy
Nurix Therapeutics
$15.90
$1.64B
-5.54
17.00%
11 Buy
0 Hold
0 Sell
Strong Buy
Sana Biotechnology
$3.29
$877.99M
-4.22
30.56%
5 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
REPL
Replimune Group
8.23
-3.88
-32.04%
AVXL
Anavex Life Sciences
4.64
-4.26
-47.87%
RCUS
Arcus Biosciences
24.56
14.86
153.20%
ORIC
Oric Pharmaceuticals
12.59
4.59
57.38%
NRIX
Nurix Therapeutics
15.90
1.36
9.35%
SANA
Sana Biotechnology
3.29
0.37
12.67%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts